Global Human Insulin Market Industry, Analysis, Growth and Demand Forecast to 2020

GLOBAL INDUSTRY INSIGHT: Global Human Insulin Market Analysis, Development and Demand Forecast to

2020

Global Human Insulin Market Analysis, Development and Demand Forecast to

2020

P&S Market Research releases a new research report with market overview, trends, DRO analysis, market

segmentation, market size, share, forecast, porter analysis, recent developments, competitive scenario and

top competitor profiles in:

Global Industry Insight: Human Insulin Market Development and Demand Forecast to 2020

Human insulin in the report refers to synthetic insulin manufactured in laboratories by growing insulin protein

with the help of E. coli bacteria.

Explore more about Global Human Insulin Market: https://www.psmarketresearch.com/market-

analysis/human-insulin-market

Key findings of Human Insulin Market:

The key findings of the report “Global Industry Insight: Human Insulin Market Development and Demand

Forecast to 2020” include:

• Increasing prevalence of diabetic population, rising prevalence of obesity, and rise in geriatric

population are major factors driving the growth of the human insulin market

• Strict regulatory requirements for approval of insulin and high cost of insulin analog inhibits the

growth of the human insulin market

• Geographically, North America has the largest share in global human insulin market, while Asia-

Pacific has emerged as the fastest growing region

• Based on the type, modern human insulin has the largest market share in the human insulin

market

Increasing usage of insulin pens for the administration of insulin helps to inject insulin accurately. In addition,

growing demand of biosimilar drugs due to its cost effectiveness is an opportunity for the growth of the

market.

Human insulin market is growing moderately due to increase in prevalence of diabetic population, rise in

geriatric population, rising awareness of diabetes and rising prevalence of obesity. However, strict

regulatory requirements for approval of insulin and high cost of analog are inhibiting the growth of the

global human insulin market.

© P&S Market Research. All rights reserved 2


2020

Globally, modern human insulin has the largest market share and is also the fastest growing human insulin

type. In addition, long acting human insulin has the largest market share in the modern human insulin

market, and premixed human insulin is the fastest growing modern human insulin in the market. Long

acting human insulin is prescribed by physicians for the treatment of type 2 diabetes. It is absorbed slowly

and works for long time to control the sugar level between meal and sleep.

Request for Report Sample: https://www.psmarketresearch.com/enquiry-

form.php?enqid=176&title=Report%20sample

The key competitors in the human insulin market include Sanofi, Novo Nordisk A/S, Eli Lilly and Company,

GlaxoSmithKline Plc, Pfizer, Inc., Merck & Co., and Julphar.

Chapter 1 Research Scope and Methodology

1.1 Market Definition

1.2 Market Breakdown by Different Categories

1.3 Market Breakdown by Geography

1.4 Research Methodology and Sources

Chapter 2 Executive Summary

2.1 Key Findings

2.2 Research Summary

Chapter 3 Market Outlook

3.1 Introduction

3.2 Trends in the Market

3.2.1 Rising usage of insulin pen for the administration of human insulin

3.3 Opportunities in the Market

3.3.1 Growing demand of biosimilar drugs due to its cost effectiveness


https://www.psmarketresearch.com/enquiry-form.php?enqid=176&title=Report%20sample



2020

3.4 Factors Driving the Market and its Impact on Market Forecast



3.4.1 Rising aging population

3.4.2 Increasing diabetic population

3.4.3 Rising prevalence of obesity

3.4.4 Technological advancement in drug delivery devices

3.4.5 Increasing awareness about diabetic care

3.4.6 Impact analysis of drivers on market forecast

3.5 Factors Hindering the Market and its Impact on Market Forecast

3.5.1 High insulin analogue cost

3.5.2 Strict regulatory requirements for approval of human insulin

3.5.3 Impact analysis of restraints on market forecast

Chapter 4 Global Market Size and Forecasts (2011 – 2020)

4.1 Global Market Breakdown by Type

4.2 Global Tradition Human Insulin Market Breakdown by Type

4.3 Global Modern Human Insulin Market Breakdown by Type

4.4 Global Market Breakdown by Region

Chapter 5 Global Market Breakdown by Type

5.1 Traditional Human Insulin Market Breakdown by Region

5.2 Modern Human Insulin Market Breakdown by Region



2020



Chapter 6 Global Traditional Human Insulin Market Breakdown by Type

6.1 Short Acting Human Insulin Market Breakdown by Region

6.2 Intermediate Acting Human Insulin Market Breakdown by Region

6.3 Premixed Human Insulin Market Breakdown by Region

Chapter 7 Global Modern Human Insulin Market Breakdown by Type

7.1 Long Acting Human Insulin Market Breakdown by Region

7.2 Rapid Acting Human Insulin Market Breakdown by Region

7.3 Premixed Human Insulin Market Breakdown by Region

Chapter 8 Global Market Breakdown by Brand

Chapter 9 Global Market Breakdown by Region

9.1 North America Market Breakdown by Country, Technology, End Users and Application

9.1.1 The U.S. market breakdown by type of human insulin, by type of traditional human insulin, and by

type of modern human insulin

9.1.2 Canada market breakdown by type of human insulin, by type of traditional human insulin, and by


9.2 Europe Market Breakdown by Country, Technology, End Users and Application

9.2.1 Germany market breakdown by type of human insulin, by type of traditional human insulin, and by


9.2.2 The U.K. market breakdown by type of human insulin, by type of traditional human insulin, and by






2020

9.2.3 France market breakdown by type of human insulin, by type of traditional human insulin, and by


9.3 Asia-Pacific Market Breakdown by Country, Technology, End Users and Application



9.3.1 Japan market breakdown by type of human insulin, by type of traditional human insulin, and by


9.3.2 China market breakdown by type of human insulin, by type of traditional human insulin, and by


9.3.3 India market breakdown by type of human insulin, by type of traditional human insulin, and by type

of modern human insulin

9.4 Rest of the World (RoW) Market Breakdown by Type, by Type of Traditional human insulin and by

Type of Modern Human Insulin

Chapter 10 Competitive Analysis and Market Share

10.1 Porter's Five Forces of Competitive Position Analysis

10.1.1 Bargaining Power of Buyers

10.1.2 Bargaining Power of Suppliers

10.1.3 Threat of New Entrants

10.1.4 Intensity of Rivalry

10.1.5 Threat of Substitutes

10.2 Competitive Positioning of Key Competitors

Chapter 11 Company Profiles

11.1 Biocon Ltd.



2020



11.1.1 Business Overview

11.1.2 Products and Services

11.1.3 Recent Developments

11.1.4 Key P&L Metrics

11.2 TonghuaDongbao Pharmaceuticals Co., Ltd





11.3 ADOCIA





11.4 Merck & Co.









2020

11.5 Julphar







11.6 Pfizer, Inc.





11.7 Bristol-Myers Squibb Company





11.8 GlaxoSmithKline Plc






2020




11.9 Oramed Pharmaceuticals, Inc.





11.10 Novo Nordisk A/S





11.11 Eli Lilly and Company





11.12 Sanofi







2020



Chapter 12 Appendix

12.1 List of Abbreviations

List of Figures

FIG. 1 Production of human insulin

FIG. 2 Aging population in major regions, in % (2000 – 2050)

FIG. 3 Number of people suffering from diabetes aged 20-79 years, 2013 and 2035

FIG. 4 Prevalence of overweight men aged 30 and above, in % (2005 and 2015)

FIG. 5 Prevalence of overweight women aged 30 and above, in % (2005 and 2015)

FIG. 6 Global human insulin market share by type (2014)

FIG. 7 Global traditional human insulin market share by type (2014)

FIG. 8 Global modern human insulin market share by type (2014)

FIG. 9 Global human insulin market share by region (2014)

FIG. 10 Global traditional human insulin market share by region (2014)

FIG. 11 Global modern human insulin market share by region (2014)

FIG. 12 Global short acting human insulin market share by region (2014)

FIG. 13 Global intermediate acting human insulin market share by region (2014)



2020



FIG. 14 Global premixed human insulin market share by region (2014)

FIG. 15 Global long acting human insulin market share by region (2014)

FIG. 16 Global rapid acting human insulin market share by region (2014)

FIG. 17 Global premixed human insulin market share by region (2014)

FIG. 18 Global human insulin market share by brand (2014)

FIG. 19 North American human insulin market share by country (2014)

FIG. 20 North America human insulin market share by type (2014)

FIG. 21 North America traditional human insulin market share by type (2014)

FIG. 22 North America modern human insulin market share by type (2014)

FIG. 23 The U.S. human insulin market share by type (2014)

FIG. 24 The U.S. traditional human insulin market share by type (2014)

FIG. 25 The U.S. modern human insulin market share by type (2014)

FIG. 26 Canada human insulin market share by type (2014)

FIG. 27 Canada traditional human insulin market share by type (2014)

FIG. 28 Canada modern human insulin market share by type (2014)

FIG. 29 Europe human insulin market share by country (2014)

FIG. 30 Europe human insulin market share by type (2014)

FIG. 31 Europe traditional human insulin market share by type (2014)

FIG. 32 Europe modern human insulin market share by type (2014)





2020



FIG. 33 Germany human insulin market share by type (2014)

FIG. 34 Germany traditional human insulin market share by type (2014)

FIG. 35 Germany modern human insulin market share by type (2014)

FIG. 36 The U.K. human insulin market share by type (2014)

FIG. 37 The U.K. traditional human insulin market share by type (2014)

FIG. 38 The U.K. modern human insulin market share by type (2014)

FIG. 39 France human insulin market share by type (2014

FIG. 40 France traditional human insulin market share by type (2014)

FIG. 41 France modern human insulin market share by type (2014)

FIG. 42 Asia-Pacific human insulin market share by country (2014)

FIG. 43 Asia-Pacific human insulin market share by type (2014)

FIG. 44 Asia-Pacific traditional human insulin market share by type (2014)

FIG. 45 Asia-Pacific modern human insulin market share by type (2014)

FIG. 46 Japan human insulin market share by type (2014)

FIG. 47 Japan traditional human insulin market share by type (2014)

FIG. 48 Japan modern human insulin market share by type (2014)

FIG. 49 China human insulin market share by type (2014)

FIG. 50 China traditional human insulin market share by type (2014)

FIG. 51 China modern human insulin market share by type (2014)





2020

FIG. 52 India human insulin market share by type (2014)

FIG. 53 India traditional human insulin market share by type (2014)

FIG. 54 India modern human insulin market share by type (2014)

FIG. 55 Rest of the World human insulin market share by type (2014)

FIG. 56 Rest of the World traditional human insulin market share by type (2014)

FIG. 57 Rest of the World modern human insulin market share by type (2014)

FIG. 58 Porter’s five forces of competitive position analysis

FIG. 59 Competitive positioning of key competitors

List of Tables

TABLE 1 Specific primary and secondary sources used for this publication

TABLE 2 Global human insulin market snapshot (2015 and 2020)

TABLE 3 Drivers for the market: Impact analysis

TABLE 4 Restraints for the market: Impact analysis

TABLE 5 Global human insulin market breakdown by type, $m (2011 – 2014)

TABLE 6 Global human insulin market breakdown by type, $m (2015 – 2020)

TABLE 7 Global traditional human insulin market breakdown by type, $m (2011 – 2014)

TABLE 8 Global traditional human insulin market breakdown by type, $m (2015 – 2020)

TABLE 9 Global modern human insulin market breakdown by type, $m (2011 – 2014)



2020



TABLE 10 Global modern human insulin market breakdown by type, $m (2015 – 2020)

TABLE 11 Global human insulin market breakdown by region, $m (2011 – 2014)

TABLE 12 Global human insulin market breakdown by region, $m (2015 – 2020)

TABLE 13 Global traditional human insulin market breakdown by region, $m (2011 – 2014)

TABLE 14 Global traditional human insulin market breakdown by region, $m (2015 – 2020)

TABLE 15 Global modern human insulin market breakdown by region, $m (2011 – 2014)

TABLE 16 Global modern human insulin market breakdown by region, $m (2015 – 2020)

TABLE 17 Global short acting human insulin market breakdown by region, $m (2011 – 2014)

TABLE 18 Global short acting human insulin market breakdown by region, $m (2015 – 2020)

TABLE 19 Global intermediate acting human insulin market breakdown by region, $m (2011 – 2014)

TABLE 20 Global intermediate acting human insulin market breakdown by region, $m (2015 – 2020)

TABLE 21 Global premixed human insulin market breakdown by region, $m (2011 – 2014)


TABLE 23 Global long acting human insulin market breakdown by region, $m (2011 – 2014)

TABLE 24 Global long acting human insulin market breakdown by region, $m (2015 – 2020)

TABLE 25 Global rapid acting human insulin market breakdown by region, $m (2011 – 2014)

TABLE 26 Global rapid acting human insulin market breakdown by region, $m (2015 – 2020)







2020

TABLE 29 Some of the human insulin drugs in pipeline by various companies

TABLE 30 Global human insulin market breakdown by brand, $m (2011 – 2014)

TABLE 31 Global human insulin market breakdown by brand, $m (2015 – 2020)

TABLE 32 North America human insulin market breakdown by country, $m (2011 – 2014)

TABLE 33 North America human insulin market breakdown by country, $m (2015 – 2020)

TABLE 34 North America human insulin market breakdown by type, $m (2011 – 2014)

TABLE 35 North America human insulin market breakdown by type, $m (2015 – 2020)

TABLE 36 North America traditional human insulin market breakdown by type, $m (2011 – 2014)

TABLE 37 North America traditional human insulin market breakdown by type, $m (2015 – 2020)

TABLE 38 North America modern human insulin market breakdown by type, $m (2011 – 2014)

TABLE 39 North America modern human insulin market breakdown by type, $m (2015 – 2020)

TABLE 40 The U.S. human insulin market breakdown by type, $m (2011 – 2014)

TABLE 41 The U.S. human insulin market breakdown by type, $m (2015 – 2020)

TABLE 42 The U.S. traditional human insulin market breakdown by type, $m (2011 – 2014)

TABLE 43 The U.S. traditional human insulin market breakdown by type, $m (2015 – 2020)

TABLE 44 The U.S. modern human insulin market breakdown by type, $m (2011 – 2014)

TABLE 45 The U.S. modern human insulin market breakdown by type, $m (2015 – 2020)

TABLE 46 Canada human insulin market breakdown by type, $m (2011 – 2014)

TABLE 47 Canada human insulin market breakdown by type, $m (2015 – 2020)

TABLE 48 Canada traditional human insulin market breakdown by type, $m (2011 – 2014)

TABLE 49 Canada traditional human insulin market breakdown by type, $m (2015 – 2020)



2020

TABLE 50 Canada modern human insulin market breakdown by type, $m (2011 – 2014)

TABLE 51 Canada modern human insulin market breakdown by type, $m (2015 – 2020)

TABLE 52 Europe human insulin market breakdown by country, $m (2011 – 2014)

TABLE 53 Europe human insulin market breakdown by country, $m (2015 – 2020)

TABLE 54 Europe human insulin market breakdown by type, $m (2011 – 2014)

TABLE 55 Europe human insulin market breakdown by type, $m (2015 – 2020)

TABLE 56 Europe traditional human insulin market breakdown by type, $m (2011 – 2014)

TABLE 57 Europe traditional human insulin market breakdown by type, $m (2015 – 2020)

TABLE 58 Europe modern human insulin market breakdown by type, $m (2011 – 2014)

TABLE 59 Europe modern human insulin market breakdown by type, $m (2015 – 2020)

TABLE 60 Germany human insulin market breakdown by type, $m (2011 – 2014)

TABLE 61 Germany human insulin market breakdown by type, $m (2015 – 2020)

TABLE 62 Germany traditional human insulin market breakdown by type, $m (2011 – 2014)

TABLE 63 Germany traditional human insulin market breakdown by type, $m (2015 – 2020)

TABLE 64 Germany modern human insulin market breakdown by type, $m (2011 – 2014)

TABLE 65 Germany modern human insulin market breakdown by type, $m (2015 – 2020)

TABLE 66 The U.K. human insulin market breakdown by type, $m (2011 – 2014)

TABLE 67 The U.K. human insulin market breakdown by type, $m (2015 – 2020)

TABLE 68 The U.K. traditional human insulin market breakdown by type, $m (2011 – 2014)

TABLE 69 The U.K. traditional human insulin market breakdown by type, $m (2015 – 2020)

TABLE 70 The U.K. modern human insulin market breakdown by type, $m (2011 – 2014)



2020



TABLE 71 The U.K. modern human insulin market breakdown by type, $m (2015 – 2020)

TABLE 72 France human insulin market breakdown by type, $m (2011 – 2014)

TABLE 73 France human insulin market breakdown by type, $m (2015 – 2020)

TABLE 74 France traditional human insulin market breakdown by type, $m (2011 – 2014)

TABLE 75 France traditional human insulin market breakdown by type, $m (2015 – 2020)

TABLE 76 France modern human insulin market breakdown by type, $m (2011 – 2014)

TABLE 77 France modern human insulin market breakdown by type, $m (2015 – 2020)

TABLE 78 Asia-Pacific human insulin market breakdown by country, $m (2011 – 2014)

TABLE 79 Asia-Pacific human insulin market breakdown by country, $m (2015 – 2020)

TABLE 80 Asia-Pacific human insulin market breakdown by type, $m (2011 – 2014)

TABLE 81 Asia-Pacific human insulin market breakdown by type, $m (2015 – 2020)

TABLE 82 Asia-Pacific traditional human insulin market breakdown by type, $m (2011 – 2014)

TABLE 83 Asia-Pacific traditional human insulin market breakdown by type, $m (2015 – 2020)

TABLE 84 Asia-Pacific modern human insulin market breakdown by type, $m (2011 – 2014)

TABLE 85 Asia-Pacific modern human insulin market breakdown by type, $m (2015 – 2020)

TABLE 86 Japan human insulin market breakdown by type, $m (2011 – 2014)

TABLE 87 Japan human insulin market breakdown by type, $m (2015 – 2020)

TABLE 88 Japan traditional human insulin market breakdown by type, $m (2011 – 2014)

TABLE 89 Japan traditional human insulin market breakdown by type, $m (2015 – 2020)





2020

TABLE 90 Japan modern human insulin market breakdown by type, $m (2011 – 2014)

TABLE 91 Japan modern human insulin market breakdown by type, $m (2015 – 2020)

TABLE 92 China human insulin market breakdown by type, $m (2011 – 2014)

TABLE 93 China human insulin market breakdown by type, $m (2015 – 2020)

TABLE 94 China traditional human insulin market breakdown by type, $m (2011 – 2014)

TABLE 95 China traditional human insulin market breakdown by type, $m (2015 – 2020)

TABLE 96 China modern human insulin market breakdown by type, $m (2011 – 2014)

TABLE 97 China modern human insulin market breakdown by type, $m (2015 – 2020)

TABLE 98 India human insulin market breakdown by type, $m (2011 – 2014)

TABLE 99 India human insulin market breakdown by type, $m (2015 – 2020)

TABLE 100 India traditional human insulin market breakdown by type, $m (2011 – 2014)

TABLE 101 India traditional human insulin market breakdown by type, $m (2015 – 2020)

TABLE 102 India modern human insulin market breakdown by type, $m (2011 – 2014)

TABLE 103 India modern human insulin market breakdown by type, $m (2015 – 2020)

TABLE 104 Rest of the World human insulin market breakdown by type, $m (2011 – 2014)

TABLE 105 Rest of the World human insulin market breakdown by type, $m (2015 – 2020)

TABLE 106 Rest of the World traditional human insulin market breakdown by type, $m (2011 – 2014)

TABLE 107 Rest of the World traditional human insulin market breakdown by type, $m (2015 – 2020)

TABLE 108 Rest of the World modern human insulin market breakdown by type, $m (2011 – 2014)

TABLE 109 Rest of the World modern human insulin market breakdown by type, $m (2015 – 2020)

TABLE 110 Biocon Ltd.– Key Facts



2020

TABLE 111 TonghuaDongbao Pharmaceuticals Co., Ltd. – Key Facts

TABLE 112 ADOCIA – Key Facts

TABLE 113 Merck & Co. – Key Facts

TABLE 114 Julphar – Key Facts

TABLE 115 Pfizer, Inc.– Key Facts

TABLE 116 Bristol-Myers Squibb Company – Key Facts

TABLE 117 GlaxoSmithKline Plc – Key Facts

TABLE 118 Oramed Pharmaceuticals, Inc. – Key Facts

TABLE 119 Novo Nordisk A/S – Key Facts

TABLE 120 Eli Lilly and Company – Key Facts

TABLE 121 Sanofi – Key Facts

About P&S Market Research

P&S Market Research is a global market research and consulting company. We provide market research

reports, industry reports, business intelligence and research based consulting services across a range of

industries.

With the help of our professional corporate relations with various companies, our market research offers

the most accurate market forecasting. Our analysts and consultants interact with leading companies of the

concerned domain to substantiate every single data presented in our publication. Our research assists our



2020

client in identifying new and different windows of opportunity and frame informed and customized

strategies for expansion in different regions.

Contact:

Deep

Assistant – Client Partner

347, 5th Ave. #1402

New York City, NY - 10016

Toll-free: +1-888-778-7886 (USA/Canada)

Email: [email protected]

Web: https://www.psmarketresearch.com


mailto:[email protected]

https://www.psmarketresearch.com/

Global Human Insulin Market Industry, Analysis, Growth and Demand Forecast to 2020

Healthcare

Transcript of Global Human Insulin Market Industry, Analysis, Growth and Demand Forecast to 2020